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Hepatoblastoma with intraatrial tumor thrombus is relatively rare. We report a case of hepatoblastoma
with tumor thrombus extending into the right atrium, which responded well to chemotherapy and was
resected using extracorporeal circulation. A 4-year-old girl was referred to our hospital because of
abdominal distention and tenderness. A computed tomography (CT) scan showed a large tumor occu-
pying the left 3 segments of the liver with tumor thrombus extending into the right atrium. There was
also a small intrahepatic metastasis in the right lobe of the liver. She was diagnosed with hepatoblastoma
on the basis of the results of open biopsy. Neoadjuvant chemotherapy with an intense CDDP-based
regimen was performed. The tumor responded well to chemotherapy, and intrahepatic metastasis
became undetectable on CT scan, although the tumor thrombus remained in the right atrium. After 7
courses of chemotherapy, we performed resection using extracorporeal circulation. The postoperative
course was uneventful, and adjuvant chemotherapy was started 10 days after the operation. Her serum
alpha-fetoprotein (AFP) level decreased to the normal range, and she was free of disease for 1 year after
the operation. Tumor resection using extracorporeal circulation can be performed safely and is justiﬁed
in patients with intraatrial tumor thrombus.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The prognosis of localized hepatoblastoma1 (HB) has improved
over the last few decades by the combination of chemotherapy and
operation [1]. Now we are confronted with the challenge of
improving the prognosis of high-risk cases such as HB with distantc Surgery, Kobe Children’s
81, Japan. Tel.: þ81 78 732
do).
CT: computed tomography,
IVC: inferior vena cava, LHV:
erior vena cava, WBC: white
Inc. This is an open access article umetastasis or local vascular invasion [2]. In the treatment of HB,
curative resection greatly improves the prognosis, and recent reports
have shown that the rate of curative resection increases with an
intense CDDP-based chemotherapy regimen [3,4]. However, there
are still cases in which surgical resection is difﬁcult even after
chemotherapy, for example, owing to invasion of the main vessels or
tumor thrombus extending into the inferior vena cava (IVC) and right
atrium. As far as we know, there are only a few reports of HB with
tumor thrombus extending into the right atrium resected using
extracorporeal circulation. We report a case of a PRETEXT IV HBwith
the tumor thrombus extending into the right atrium through the left
hepatic vein (LHV), which responded well to chemotherapy and was
resected using extracorporeal circulation (ECC).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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A previously healthy 4-year-old girl presented at a local hospital
with complaints of fever, abdominal distention, and pain. Physical
examination revealed tenderness in the entire abdomen with
Blumberg sign, and laboratory data showed a signiﬁcantly elevated
white blood cell (WBC) count and serum C-reactive protein (CRP)
levels (33,700/ml and 15.4 mg/dl, respectively). She was diagnosed
with acute abdomen and referred to our hospital.
Physical examination revealed a huge tumor palpated around
the epigastric fossa. Laboratory data showed an elevated WBC
count and serum CRP level. Serum alpha-fetoprotein (AFP) was
305,000 ng/ml. A computed tomography (CT) scan showed a large
heterogeneous tumor occupying the left 3 segments of the liver
with tumor thrombus extending into the right atrium through the
LHV. There was also a small nodule in the right lobe of the liver,
which was suspected to be an intrahepatic metastasis (Fig. 1A). No
apparent distant metastases were identiﬁed by head and chest CT
or bone scintigraphy. Open biopsy of the tumor conﬁrmed the
diagnosis of HB, mixed epithelial type. The patient was enrolled in
the Japanese Study Group for Pediatric Liver Tumor and underwent
neoadjuvant chemotherapy with biweekly CDDP and carboplatin/
adriamycin according to the regimen of the International Childhood
Liver Tumors Strategy Group3-HR under the diagnosis of PRETEXT
IV HB. The tumor showed a good response to chemotherapy and
shrank signiﬁcantly, and the intrahepatic metastasis in the right
lobe of the liver became undetectable on CT scan (Fig. 1B). No
apparent distant metastasis was revealed by chest CT scan. The
tumor thrombus also shrank signiﬁcantly but still existed in the
right atrium. The rate of decrease of the serum AFP level lessened
gradually, and we judged that the tumor thrombus would not
disappear even if we continued chemotherapy. After 7 courses of
chemotherapy, we performed the operation.
We performed thoracotomy ﬁrst and isolated the ascending
aorta and superior vena cava (SVC) beforehand in case a pulmonary
embolus occurred. Then, an inverted Y-shaped incision was made
on the abdomen. Intraoperative ultrasonography revealed that the
tumor had shrunk since the last CT scan, and no metastatic lesionFig. 1. A) Computed tomography (CT) scan on admission. A huge tumor occupied the left 3
also a small nodule in the right lobe of the liver, which was suspected to be an intrahepatic
tumor shrank signiﬁcantly, and the intrahepatic metastasis in the right lobe of the liver bewas detected in the right lobe of the liver. We considered the tumor
resectable by extended left hemihepatectomy with thrombectomy
in the right atrium.
The infrahepatic IVC was exposed and encircled with vascular
tape for extracorporeal circulation. The liver was mobilized from its
ligamentous attachments, and the right hepatic vein was dissected
and controlled with vascular tape. Then, we dissected the liver
parenchyma using Pringle’s maneuver. After ﬁnishing the dissec-
tion of the liver parenchyma, leaving the left lobe connected to the
IVC by only the common trunk of the middle hepatic vein and LHV,
we moved to the tumor thrombectomy using ECC. Cardiopulmo-
nary bypass was instituted using cannulation of the ascending
aorta, SVC, and infrarenal IVC. A pump sucker was also used during
resection of the suprahepatic IVC. The tumor thrombus was free
from the right atrium but partly adhered to the wall of the supra-
hepatic IVC, which was resected with the tumor thrombus and
reconstructed with a pericardial membrane patch. The operation
time was 14 h, 49 min, and ECC time was 45 min. Total blood loss
was 743 ml. The resected tumor was diagnosed as a combined fetal
and embryonal type of hepatoblastoma on histopathological
examination. Viable cells were found in the tumor thrombus. The
postoperative course was uneventful, and adjuvant chemotherapy
was started 10 days after the operation. Three courses of adjuvant
chemotherapy were completed as scheduled without any signiﬁ-
cant side effects. The patient’s serum AFP level decreased to the
normal range (Fig. 2), and CT and MRI revealed no apparent signs of
local recurrence in the remnant liver or any distant metastasis. She
was free of disease for 1 year after the operation.
2. Discussion
We experienced a case of HB with the tumor thrombus
extending into the right atrium. At the ﬁrst medical examination,
the huge tumor occupied the left 3 segments of the liver with tumor
thrombus extending into the right atrium through the LHV, and
there was intrahepatic metastasis in the right lobe. HB is the most
frequent primary malignant liver tumor in children, accounting for
almost two thirds of such tumors [5,6]. In many cases, childrenwithsegments of the liver with tumor thrombus extending into the right atrium. There was
metastasis (arrow). B) CT scan after 7 courses of neoadjuvant chemotherapy. The main
came undetectable. The tumor thrombus still existed in the right atrium.
Fig. 2. Serum alpha-fetoprotein (AFP) level. AFP level decreased signiﬁcantly in
response to the chemotherapy and became within normal range after the operation.
AFP level remained within the normal range for 1 year after the operation.
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are in the advanced stages at diagnosis [5]. However, there are only
a few reports of HB with an intraatrial tumor thrombus.
Unlike hepatocellular carcinoma, HB is generally sensitive to
chemotherapy, and recently, an intense CDDP-based regimen has
been reported to have a high response rate [1e4]. Loh et al. reported
2 cases of HB with tumor thrombus into the right atrium. In both
cases, chemotherapy was highly effective, and the tumor thrombus
decreased in size up to below the diaphragm, and hepatic resections
were performedwithout ECC [7]. There is even a case report inwhich
a patient with highly advanced HB remained in remission by
chemotherapy without any surgical resection [8].
Chemotherapy was highly effective in our case as well. The
main tumor shrank signiﬁcantly, and the intrahepatic metastasis
disappeared, although the tumor thrombus still existed in the
right atrium. The rate of decrease of the AFP level plateaued
gradually. Thus, we decided to perform tumor resection using ECC.
Application of ECC to oncologic surgery is controversial.
Hasegawa et al. reported a case of intrapulmonary tumor spread
after surgical resection of intrathoracic extension of thyroid cancer
with cardiopulmonary bypass [9]. On the other hand, Kauffmann
et al. reported that surgery on ECC for advanced non-small cell lung
carcinoma resulted in satisfactory results without surgery-induced
tumor propagation [10]. In our case, the rate of decrease of the AFP
level gradually became slower throughout the course of neo-
adjuvant chemotherapy. As surgical resection should be performed
before tumors become resistant to chemotherapy, we considered
that ECC was inevitable for the resection. There was no evidence of
recurrence for 1 year after the operation, which might indicate that
the adjuvant chemotherapy was effective for the tumor. We believe
that resection on ECC would be justiﬁed for cases of HB because the
resectability of the tumor has a great impact on the prognosis of this
disease.
Using the pump sucker during the operation for a malignancy is
uncommon, because it could increase the risk of tumor propaga-
tion. However, since in our case, preoperative chemotherapy was
highly effective and the tumor thrombus had shrunk signiﬁcantly,
and preoperative echocardiography showed no invasion of the
tumor thrombus into the right atrial wall, we thought that we couldcontrol the micro-metastasis if we resected the tumor thrombus en
block and began adjuvant chemotherapy early after the operation.
We made the operative procedure simple by using a pump sucker
and ECC with the heart beating, which attributed to the early
postoperative recovery and the resultant early initiation of adjuvant
chemotherapy. As a result, we believe we could control the insid-
ious micro-metastasis.
In our case, liver transplantation (LTx) might have been another
surgical treatment option, because the survival rates after primary
LTx are reported to be remarkably higher than those after rescue
LTx, incomplete resectionwith partial hepatectomy, or relapse after
a previous partial hepatectomy [11]. However, macroscopic venous
invasion was reported to be an independent risk factor of overall
survival after primary LTx [11,12]. We refrained from LTx for fear
that an insidious micro-metastatic lesion might recur due to the
immunosuppressed status after LTx.3. Conclusions
In summary, we experienced a case of PRETEXT IV HBwith tumor
thrombus extending into the right atrium. Since complete resection
of the tumor is considered essential for the cure of HB, we concluded
that tumor resection using ECC could be justiﬁed in a patientwith HB
extending into the right atrium.
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